Clinical Research Details Clinical Research A Multi-Center Phase 2/3 Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Safety and Efficacy Study of Dapansutrile Tablets in Subjects with an Acute Gout Flare Study Description The main purpose of this study is to see how well dapansutrile reduces joint pain and other joint symptoms (such as tenderness and swelling) because of an acute gout flare compared with placebo. A placebo is an inactive material that looks like dapansutrile but does not have any dapansutrile in it. Researchers use a placebo to see if dapansutrile works better than taking nothing and is safe to use. From here on, dapansutrile and placebo will be referred to as the 'study drug'. Inclusion/Exclusion Criteria - Male and female subjects ≥ 18 years of age - Clinical diagnosis of gout - Able and willing to provide written informed consent prior to initiation of any study related procedures Open Enrollment Contact Name: Caroline HowardContact Phone: (904) 633-0914Contact Email: caroline.howard@jax.ufl.edu Investigators Gurjit S. Kaeley, M.B.B.S. (M.D.) Medicine